The DECADE data show a higher risk of death, MI, and stent thrombosis in people who smoked at the time of PCI with DES.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Overall, there was a “modest” decline in use of embolic protection in the year after the PROTECTED TAVR results were released ...

Along with tafamidis and acoramidis, the drug is now the third for ATTR-CM, but it comes with a whopping price tag of ...

In this “data-scarce zone,” the paper offers a road map for the first 24 hours and tips for transfer, teams, and more.

With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...

With about 7% of CVD in the country attributable to high temperatures, experts say tools to adapt are urgently needed.

Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.

For many of these conditions, women present later and sicker, and are less likely to be treated appropriately.

Clinicians should be asking patients about cannabis use, particularly if there are cardiovascular concerns, say researchers.

Early data in mice and human tissue indicate that using drugs or gene therapy could allow for cardiac healing in ischemic HF.

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...